Post-acute capacity is an episode portfolio

01 / THE ARGUMENT

A network directory is not a capacity portfolio

MedPAC's March 2026 home-health analysis reports broad geographic provider availability but warns that the presence of an agency does not establish its ability to accept additional patients. Its skilled-nursing analysis likewise notes that local occupancy and specialized service needs can constrain access even where facilities exist. These are specific measurement limitations, rather than evidence that every market has the same shortage.[1][2]

The practical implication is to maintain a portfolio of usable capabilities: a staffed bed for the relevant needs, a confirmed home-health start, appropriate therapy, dependable equipment and a plan for medication access. Each capability has a geography, operating window, payer arrangement and constraint. The portfolio becomes valuable when those facts are current enough to support a real choice. A long preferred-provider list can hide the same bottleneck repeatedly if every apparent alternative relies on one scarce team or service.

02 / THE ARGUMENT

Make patient fit the boundary condition

A Yale and University of Michigan study used the Medicare eligibility threshold at age 65 in more than 1.5 million trauma encounters. Medicare entry was associated with shorter hospital stays and changed discharge destinations, with little change in in-hospital treatment or mortality. The study identifies discharge as a coverage-sensitive part of the pathway; it does not prove that a particular destination is better for all patients.[3]

My recommended allocation process begins with clinical needs, functional status, patient preference and the conditions needed for a workable receiving environment. Only clinically appropriate options enter the economic comparison. Expected reimbursement or a favorable per-day price should not manufacture suitability. Document why an option is feasible, what support it requires and what happens if that support fails. The most valuable alternative may be the one that can reliably start the right service, rather than the one with the lowest nominal rate.

03 / THE ARGUMENT

The transition extends beyond the destination

The 2026 Med AAAction design paper describes a pragmatic randomized trial in low-income adults that combines medication affordability, bedside and home delivery, coaching and care coordination after discharge. Its publication establishes that the intervention is being tested; it does not establish reductions in readmissions or expenditure. It is a useful contemporary example of a transition intervention whose boundary includes access work after the hospital exit.[4]

My episode design would therefore track the receiving service's actual start, a reconciled medication plan, necessary equipment, an identified clinician and the next contact. Discharge documentation alone is not closure. If a person reaches home without the prescribed equipment or an agency accepts a referral without scheduling the first visit, the handoff remains open. Give one transition owner the authority to see these exceptions and obtain a response from the institution responsible for each unresolved task.

04 / THE ARGUMENT

Contract for specific capabilities and transparent exceptions

I would organize the commercial arrangement in two layers. The first specifies the receiving services, eligibility boundaries, information required, response windows and escalation contacts. The second defines episode measurement and the economic treatment of delays, extra support and failed starts. A capacity commitment is credible only if the staffing, equipment and operating schedule behind it are visible enough to verify. Prefer contracts that identify a bottleneck explicitly to agreements promising comprehensive coverage that nobody can operationally supply.

For constrained markets, consider a time-limited capability investment with a defined exit condition: an added weekend start-of-care team, an equipment arrangement or a specialist service for an otherwise appropriate receiving site. Evaluate incremental capacity against actual eligible demand and patient choice. Any reservation or availability payment requires legal and contracting review; it must not become a referral inducement or a substitute for appropriate placement. Partners should be able to report declined referrals accurately without being punished for protecting safety.

05 / THE ARGUMENT

Price the episode, then learn which constraint matters

The proposed economic model includes hospital resources used during avoidable waiting, receiving-provider cost, coordination, equipment, medication access and subsequent utilization. A shorter stay can release capacity, but multiplying released days by an average charge does not establish cash savings. Distinguish marginal resources avoided from potential throughput, and count throughput value only when demand and staffed hospital capacity support it. Reduced expense for one party may simply transfer cost to another institution or to the household.

Run the portfolio as a measured operating process. Compare the clinical populations and choices before interpreting destination-level outcomes. Review functional recovery, patient burden, failed service starts and unplanned returns alongside spending. MedPAC's recommendations for future payment updates should inform scenario planning, not be booked as implemented rates.[1][2] Expand the capability that measurably resolves the dominant local constraint. The executive standard is a receiving pathway that works for the patient and remains economically viable for the institutions expected to deliver it.

FROM EVIDENCE TO ALLOCATION

The operating and investment case

Proposed design by Azis R. Dabas. These decisions and evaluation criteria are not outcomes established by the cited studies.

Decision: Select one transition cohort and geography; fund the receiving capability that demonstrably constrains clinically appropriate episode completion.
Accountable owner: Hospital care-management and operations leadership with payer contracting and the receiving home-health/SNF network; clinical leadership retains placement and safety oversight.

The delivery sequence

Define clinical suitability, patient preference and required support.
Confirm current staffed capabilities, accepting payer arrangements and service-start windows.
Resolve authorization, information, equipment and medication handoffs.
Select among appropriate options with the person and document constraints.
Confirm receiving-service initiation and assign unresolved exceptions.
Measure recovery, patient burden, utilization and incremental episode cost.

The economics

Compare net episode resources and sustainable partner economics, separating marginal avoided cost from conditional throughput value and transfers. Price any added capability against eligible local demand; do not claim savings from destination or length of stay alone.

The measures that govern expansion

Time from clinically ready to actual receiving-service start
Failed or delayed starts by constraint
Appropriate options available at the decision time
Medication and equipment handoff completion
Functional recovery and patient-reported burden
Risk-adjusted unplanned returns
Incremental episode cost and receiving-partner sustainability

Stop or redesign when

Pause a pathway if suitability or informed choice is compromised, capacity commitments are routinely unmet, patient burden rises, or apparent hospital savings depend on transferring unmeasured cost to households or partners.

THE EVIDENCE LEDGER

What supports the argument

Study findings, policy requirements and market signals support different claims. Their boundaries remain visible.

[1] policy · March 12, 2026

Chapter 8: Home health care services, March 2026 Report to the Congress

Design or status: Federal payment-adequacy assessment using administrative and industry evidence, primarily 2024 experience
Verified finding: Provider-count measures indicate broad geographic availability but do not establish an agency's capacity to accept additional patients. Future payment updates are recommendations to Congress.
Boundary: Fee-for-service population and lagged data; geographic availability is not real-time patient-level access.

[2] policy · March 12, 2026

Chapter 7: Skilled nursing facility services, March 2026 Report to the Congress

Design or status: Federal payment-adequacy assessment using administrative and industry evidence, primarily 2024 experience
Verified finding: Overall access indicators were mostly positive, while high local occupancy and specialized care needs could constrain access. The chapter proposes a future payment update rather than enacting one.
Boundary: National and lagged FFS indicators cannot determine availability, patient fit or quality of an individual facility today.

[3] peer-reviewed · July 11, 2023

Association between Medicare eligibility at age 65 years and in-hospital treatment patterns and health outcomes for patients with trauma: regression discontinuity approach

Design or status: Regression discontinuity at Medicare age eligibility using 1,586,577 trauma encounters, 2007–2017
Verified finding: Medicare entry was associated with shorter stays and changed discharge locations, with little change in in-hospital treatment or mortality.
Boundary: Trauma patients near age 65 and historical data; not an evaluation of a contemporary post-acute capacity program or optimal placement.

[4] peer-reviewed · April 18, 2026

The Medication Affordability, Accessibility, and Availability in Care Transitions (Med AAAction) Study: Design and methods for a pharmacy-led trial implemented in low-income populations

Design or status: Design and methods paper for a pragmatic randomized controlled trial
Verified finding: Describes testing a multicomponent post-discharge medication-access intervention combining affordability, delivery, coaching and coordination.
Boundary: Protocol/design publication; it provides no completed efficacy result for readmissions, adherence or costs.

FOLLOW THE SOURCE

Sources and editorial method

Selected evidence was reviewed through October 7, 2026. Numbered references connect claims to their underlying records. Economic mechanisms and business cases are the author’s analysis unless a source is cited. The review is selective; publication dates retain the precision available in the source.

Chapter 8: Home health care services, March 2026 Report to the Congress
Medicare Payment Advisory Commission. MedPAC Report to the Congress: Medicare Payment Policy. March 12, 2026. policy.
Primary verification record
Chapter 7: Skilled nursing facility services, March 2026 Report to the Congress
Medicare Payment Advisory Commission. MedPAC Report to the Congress: Medicare Payment Policy. March 12, 2026. policy.
Primary verification record
Association between Medicare eligibility at age 65 years and in-hospital treatment patterns and health outcomes for patients with trauma: regression discontinuity approach
Deepon Bhaumik, Chima D Ndumele, John W Scott, Jacob Wallace. The BMJ. July 11, 2023. peer-reviewed.
DOI: 10.1136/bmj-2022-074289 · Primary verification record · Consensus paper record
The Medication Affordability, Accessibility, and Availability in Care Transitions (Med AAAction) Study: Design and methods for a pharmacy-led trial implemented in low-income populations
Yamini Mallisetty, Rushin Shah, Thomas Kerby, Hadii M Mamudu, James E Bailey, KariLynn Dowling-McClay, Csaba P Kovesdy, Cameron Kaplan, Shauntá Chamberlin, Ashlee Hawkins, Elizabeth A Tolley, J Carolyn Graff, Cori Cohen Grant, Susan W Butterworth, Satya Surbhi. Contemporary Clinical Trials; issue June 2026. April 18, 2026. peer-reviewed.
DOI: 10.1016/j.cct.2026.108320 · Primary verification record · Consensus paper record

Study authors retain credit for their work. Researcher affiliations and publisher names do not imply affiliation with or endorsement of this analysis.